Entera Bio Ltd. (ENTX) vs Iambic Therapeutics, Inc. (IAM)

Entera Bio Ltd. ENTX 3.13 +4.68%
Iambic Therapeutics, Inc. IAM 10.20 −12.37%

Entera Bio Ltd. and Iambic Therapeutics, Inc. are both Biotechnology companies. Entera Bio Ltd. and Iambic Therapeutics, Inc. are of similar size ($551.7M and $520.0M).

Metric	ENTX	IAM	Biotechnology median
P/E	n/m	—	10.60
P/S	708.12	—	9.40
P/B	21.73	—	2.13
Price to free cash flow	n/m	—	25.18
EV/EBITDA	n/m	—	0.66
EV/Sales	642.93	—	9.02
Earnings yield	(11.18%)	—	(32.88%)
Free cash flow yield	(6.96%)	—	(23.13%)

Metric	ENTX	IAM	Biotechnology median
Gross margin	0.00%	—	68.51%
Operating margin	0.00%	—	0.00%
Net margin	0.00%	—	0.00%
Free cash flow margin	0.00%	—	0.00%
Return on equity	(138.92%)	—	(51.96%)
Return on assets	(87.02%)	—	(46.06%)
Return on invested capital	0.00%	—	0.00%

Metric	ENTX	IAM	Biotechnology median
Revenue growth (TTM)	66.42%	—	6.76%
EPS growth (last fiscal year)	0.00%	—	29.88%
Revenue growth, 5-year CAGR	(29.19%)	—	9.75%
Net income growth, 5-year CAGR	0.00%	—	0.00%

Metric	ENTX	IAM	Biotechnology median
Debt to equity	0.00	—	0.00
Current ratio	8.98	—	4.97
Net debt to EBITDA	1.29	—	1.01

Metric	ENTX	IAM	Biotechnology median
Dividend yield	—	—	0.41%
Payout ratio	—	—	—

Metric	ENTX	IAM	Biotechnology median
Market cap	520.03m	551.74m	161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack